CROX vs HLI: How Crocs and Houlihan Lokey Compare (2026)

Same yardstick, side by side (as of July 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: CROX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. CROX and HLI share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined CROX and HLI exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Crocs, Inc. designs and sells casual footwear under two brands. The Crocs Brand centers on its signature molded clog made from a proprietary closed-cell resin the company calls Croslite, extended through sandals, sneakers, and the Jibbitz charms that let buyers personalize their shoes. In 2022 Crocs acquired HEYDUDE, a lightweight casual-shoe brand, to add a second growth engine. The company sells through wholesale partners and a growing direct-to-consumer channel that includes its own websites and stores, and it markets heavily through collaborations and celebrity tie-ins. Crocs is known for operating margins well above most footwear peers, driven by a simple core product, strong pricing, and relatively low marketing spend versus sales.

Full CROX guide

Houlihan Lokey, Inc. (NYSE: HLI) is an independent, advisory-focused investment bank founded in 1972 and headquartered in Los Angeles. It advises corporations, private equity sponsors, and governments across three segments: Corporate Finance (M&A and capital-raising, the largest slice at roughly two-thirds of revenue), Financial Restructuring (out-of-court workouts and bankruptcy advisory, where it is a global market leader by deal volume), and Financial and Valuation Advisory (fairness opinions, portfolio valuation, and financial consulting). Unlike bulge-bracket banks, Houlihan Lokey does not trade for its own account or make large loans, so its revenue is almost entirely advisory fees.

Full HLI guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• CROX drivers: High-margin core Crocs Brand; Cash generation and share buybacks.
• HLI drivers: Restructuring ballast; M&A and capital-markets recovery.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The largest risk is that Crocs depends heavily on one iconic product, so a shift in fashion or a fading of the clog trend could hurt demand quickly, and single-product concentration makes the stock sensitive to sentiment about the brand's staying power. For HLI, advisory revenue is inherently lumpy and tied to deal completions, so a prolonged M&A slowdown or credit freeze can pressure results even with the restructuring hedge.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick CROX if you believe its drivers more; HLI if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the CROX and HLI guides.

CROX. These figures are approximate, tied to the asOf date, and change with new filings and market moves, so verify live numbers before acting. A low forward P/E on Crocs reflects skepticism about whether current profitability lasts, especially given the HEYDUDE drag and single-product concentration, so the cheap multiple is a judgment about risk rather than a guarantee of value. Guidance can be revised, and tariff or demand shifts can move the numbers meaningfully.

HLI. At roughly $137 per share in mid-July 2026, HLI trades near a market cap of about $11.4 billion, with a trailing P/E around 22x that sits below its multi-year median. The dividend was raised about 17 percent to $0.70 per quarter (roughly $2.80 annualized). The 52-week range has been wide (roughly $131 to $212), reflecting the market's shifting expectations for deal activity.

Headline figures (approximate, Jul 2026): CROX shows revenue (annual) roughly $4 billion range across both brands, q1 2026 revenue ~$921 million, down modestly year over year, fy2026 adjusted eps guidance company guided to roughly $13.20 to $13.75 (adjusted, subject to revision), operating margin unusually high for footwear, historically in the mid-20s percent range enterprise-wide; HLI shows revenue (fy2026, ended mar 2026) ~$2.62B, net income (fy2026) ~$426M, diluted eps (fy2026) ~$6.22, adjusted eps (fy2026) ~$7.56.

CROX and HLI are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined CROX and HLI exposure against your real portfolio. It is not an investment adviser.